Peregrine Pharmaceuticals reported $15.24M in Stock for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Amgen AMGN:US $ 4152M 37M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Bristol Myers Squibb BMY:US $ 2163M 26M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Flexion Therapeutics FLXN:US $ 14.67M 2.37M
GlaxoSmithKline GSK:LN 6244M 86M
Intrexon XON:US $ 9.94M 1.48M
Karyopharm Therapeutics KPTI:US $ 3.94M 38K
Mannkind MNKD:US $ 7.48M 0M
Novartis NOVN:VX SF 6885M 226M
Novavax NVAX:US $ 0 0
Peregrine Pharmaceuticals PPHM:US $ 15.24M 3.37M
Repligen RGEN:US $ 156.16M 20.65M